First author, year [ref] | N | Mean age (range) (years) | Duration therapy (months) | Trial design | Tests |
---|---|---|---|---|---|
Ahmad, 2001 [28] | 46 | Unknown | 3 | Open | QoL-AGHDA |
Baum, 1998 [29] | 40 | Median 51 (24–64) | 18 | Controlled | NHP, PGWB, GHQ, MMPI-2 |
Burman, 1995 [30] | 36 | 46 (28–57) | 9 | Controlled | NHP, PGWB, HSCL |
Carroll, 1997 [31] | 38 | 42.9 | 6 | Controlled | NHP, PGWB |
Cuneo, 1998 [32] | 83 | 41.2 | 12 | Controlled-open | NHP |
Degerblad, 1990 [33] | 6 | 20–38 | 3 | Controlled | Sjoberg, POMS |
Deijen, 1998 [34] | 48 | 27 (19–37) | 24 | Controlled-open | POMS vigor, STAI state, HSCL |
Giusti, 1998 [35] | 26 | 51 (21–74) | 6 | Controlled | KSQ, HDS |
Hernberg, 2001 [36] | 304 | M: 50.8 F: 48.6 | 12 | Open | QoL-AGHDA, VAS |
Murray, 1999 [37] | 65 | 38.7 (17–72) | 8 | Open | QoL-AGHDA, PGWB |
Sartorio, 1995 [38] | 8 | 29.6 (25–34) | 6 | Open | Dysphoria, Anxiety |
Soares, 1999 [39] | 9 | 39.4 (28–52) | 12 | Controlled-open | HDS, BDI |
Stouthart, 2003 [9] | 20 | 21 (17–27) | 12 | Open | QLS, STAI, POMS, SCL-90, HSCL |
Wallymahmed, 1997 [40] | 30 | 35 | 24 | Controlled-open | NHP, MFQ |
Wiren, 1998 [41] | 71 | 45 (19–76) | 24 | Open | NHP, PGWB |